ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction

This study has been terminated.

Sponsored by: Repligen Corporation
Information provided by: Repligen Corporation
ClinicalTrials.gov Identifier: NCT00036231
  Purpose

The purpose of the study is to determine the effect of multiple doses of secretin on autism.


Condition Intervention Phase
Autism
Drug: RG1068 (Synthetic Human Secretin)
Phase III

MedlinePlus related topics:   Autism   

Drug Information available for:   Secretin    Human secretin   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study
Official Title:   A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism and Gastrointestinal Dysfunction

Further study details as provided by Repligen Corporation:

Study Start Date:   April 2002

  Eligibility
Ages Eligible for Study:   32 Months to 59 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria
  • Autism
  • Gastrointestinal dysfunction
  Contacts and Locations

No Contacts or Locations Provided
  More Information


Related Info  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   RG1068-03
First Received:   May 8, 2002
Last Updated:   November 17, 2005
ClinicalTrials.gov Identifier:   NCT00036231
Health Authority:   United States: Food and Drug Administration

Study placed in the following topic categories:
Child Development Disorders, Pervasive
Developmental Disabilities
Secretin
Mental Disorders
Autistic Disorder
Mental Disorders Diagnosed in Childhood

Additional relevant MeSH terms:
Therapeutic Uses
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists
Gastrointestinal Agents
Hormones
Pharmacologic Actions

ClinicalTrials.gov processed this record on November 30, 2008




Links to all studies - primarily for crawlers